Log in to your Inderes Free account to see all free content on this page.

Sectra

275.2

SEK

-0.22 %

Less than 1K followers

SECT B

NASDAQ Stockholm

Medical Equipment & Services

Health Care

Overview

Ownership

Investor consensus

-0.22%

+8.24%

+10.26%

-0.52%

-3.51%

+28.14%

+106.02%

+228.75%

+16,303.52%

Sectra operates in the medical technology industry and focuses on the development and manufacture of systems for imaging diagnostics and secure communication. The company's products are aimed at healthcare institutions and doctors. The business is conducted internationally, where the company sells through collaboration with partners all over the world. Sectra was founded in 1957 and is headquartered in Linköping.

Market cap

53.7B SEK

Turnover

35.48M SEK

Revenue

EBIT %

P/E

Dividend yield-%

Financial calendar

5.6.

2025

Annual report '25

9.9.

2025

General meeting '25

All

Webcasts

Press releases

ShowingAll content types

Press release4/15/2025, 6:35 AM

Leading Australian private hospital chooses Sectra's enterprise imaging solution for efficient workflows and better patient outcomes

Press release4/8/2025, 6:46 AM

Sectra's fully managed AI offering extended to include pathology following new Amplifier partner agreement

Sectra, Capital Markets Day, CMD, 2025

Webcast3/27/2025, 11:30 AM

Sectra, Capital Markets Day, CMD, 2025

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account

Stock market's most popular morning newsletter

Analyst comments and recommendations

Stock comparison tool

PREMIUM account

All company reports and content

Premium tools (e.g. insider transactions & stock screener)

Model portfolio

Press release3/27/2025, 7:45 AM

Sectra's Capital Markets Day 2025-focus on medical diagnostic IT operations

Regulatory press release3/14/2025, 7:15 AM

Sectra's nine-month interim report 2024/2025: The industry's most satisfied customers for the twelfth consecutive year

Press release3/10/2025, 7:35 AM

Sectra delivers solution to the Swedish Prison and Probation Service for secure access to information

Press release3/6/2025, 7:35 AM

Top-rated US health system expands Sectra's enterprise imaging solution with digital pathology to enhance collaboration for improved cancer care

Press release3/4/2025, 7:35 AM

Sectra receives new orders from Swedish authorities to strengthen the ability to communicate securely

Press release2/27/2025, 7:35 AM

Invitation to presentation of Sectra's nine-month interim report 2024/2025

Press release2/24/2025, 7:30 AM

Enhancing radiology workflows: Sectra and Siemens Healthineers enable seamless integration across systems for better patient care

Press release2/11/2025, 7:30 AM

Large Swedish healthcare region expands use of Sectra's solution with digital pathology to enhance cancer diagnostics

Press release2/5/2025, 2:00 PM

Sectra keeps #1 position in customer satisfaction-earns 8 Best in KLAS awards within radiology and digital pathology

Press release1/29/2025, 7:30 AM

Invitation to Sectra's 2025 Capital Markets Day

Press release12/17/2024, 7:30 AM

University of Hartford adopts Sectra's service to improve education and speed up onboarding of radiographers

Regulatory press release12/12/2024, 7:15 AM

Sectra's six-month interim report 2024/2025: Order bookings at a record high

Press release12/9/2024, 7:30 AM

Norwegian healthcare region expands enterprise imaging contract with Sectra-digitizes pathology diagnostics to improve cancer care

Regulatory press release11/29/2024, 8:25 AM

Change in number of shares outstanding in Sectra AB during November

Press release11/28/2024, 9:00 AM

Invitation to presentation of Sectra's six-month interim report 2024/2025 and date for CMD

Press release11/28/2024, 7:31 AM

Belgian hospital chooses Sectra's enterprise imaging solution to support faster radiology diagnostics for better patient care

Press release11/25/2024, 7:31 AM

French hospital joins regional pathology solution from Sectra to enhance collaboration and speed up cancer diagnostics

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.